Most consumer wearables estimate pulse using photoplethysmography (PPG), an optical technique that detects blood volume changes under the skin. Medical-grade measurements use electrocardiogram (ECG) signals to measure the heart’s electrical activity. Accuracy therefore depends on sensor type, placement, signal processing and the use case: casual heart rate tracking, exercise monitoring, or clinical diagnosis each require different precision.
What affects accuracy
Motion and vibration create motion artifact that distorts PPG signals; activities with rapid arm movement or impact reliably reduce wrist-based accuracy. Skin pigmentation and tissue characteristics influence light absorption—deeper melanin absorption and thicker subcutaneous tissue can lower signal quality—so darker skin tones and heavy tattoos sometimes increase error. Poor device fit, loose straps, low peripheral perfusion from cold or vasoconstriction, and ambient light leaking into the sensor also degrade readings. Algorithm design matters: manufacturers apply filtering and heuristics to remove noise, and these software choices produce measurable differences between brands.
Large-scale evidence highlights both promise and limits. The Apple Heart Study led by Mintu P. Turakhia, Stanford Medicine demonstrated that a smartwatch-based irregular rhythm notification can identify atrial fibrillation signals at population scale but also required follow-up ECG confirmation, illustrating that optical wrist sensors are useful for screening but not a substitute for diagnostic ECG. Commentary from Eric J. Topol, Scripps Research emphasizes that consumer wearables can transform longitudinal monitoring while cautioning about variable accuracy across contexts and populations.
Clinical and real-world consequences
For resting heart rate and low-intensity activities, many wrist PPG devices provide reasonable agreement with reference methods, often close enough for fitness tracking and trend monitoring. During moderate-to-high intensity exercise or when precise beat-to-beat timing is required, wrist PPG routinely loses fidelity; chest straps that capture ECG-like signals tend to remain accurate because they measure electrical activity directly. The U.S. Food and Drug Administration has cleared some wearable features such as single-lead ECG apps for specific uses, reflecting that regulatory review expects device-specific validation and limits on intended use.
Consequences of misinterpreted readings range from unnecessary anxiety and medical visits to missed diagnoses if a false negative suppresses care-seeking. There are social and equity considerations: populations with darker skin or occupations involving repetitive arm motion may get systematically poorer performance, and the cost of higher-quality devices can concentrate benefits in wealthier regions or communities.
In practice, use wrist-based heart rate for general fitness trends, sleep and large changes in resting rate, but rely on ECG-capable devices or clinical testing when accurate rhythm diagnosis or therapy decisions are at stake. Understanding device limits, checking manufacturer validation studies, and discussing concerning signals with a clinician will mitigate most risks while preserving the benefits of continuous wearable monitoring.